Randomized Phase III Trial of Cisplatin and Irinotecan (NSC-616348) Versus Cisplatin and Etoposide in Patients With Extensive Stage Small Cell Lung Cancer (E-SCLC)
Randomized Phase III Trial of Cisplatin and Irinotecan (NSC-616348) Versus Cisplatin and Etoposide in Patients With Extensive Stage Small Cell Lung Cancer (E-SCLC)
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether cisplatin combined with irinotecan is more effective than cisplatin combined with etoposide in treating extensive-stage small cell lung cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of cisplatin combined with either irinotecan or etoposide in treating patients who have extensive-stage small cell lung cancer.
OBJECTIVES:
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to number of metastatic sites (single vs multiple), lactic dehydrogenase (no greater than upper limit of normal (ULN) vs greater than ULN), and weight loss in the past 6 months (5% or less vs more than 5%). Patients are randomized to 1 of 2 treatment arms.
Treatment in both arms continues for 4 courses in the absence of disease progression or unacceptable toxicity.
Patients are followed every 3 months for 1 year and then every 6 months for 2 years.
PROJECTED ACCRUAL: A total of 620 patients (310 per treatment arm) will be accrued for this study within 4 years.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
Age
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
Other
PRIOR CONCURRENT THERAPY:
Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
Other
Tucson, Arizona 85724-5024, United States
Fort Smith, Arkansas 72903, United States
Little Rock, Arkansas 72205, United States
Concord, California 94524-4110, United States
Los Angeles, California 90089-9181, United States
Palm Springs, California 92262, United States
Pensacola, Florida 32514, United States
Savannah, Georgia 31403-3089, United States
Valdosta, Georgia 31603, United States
Maywood, Illinois 60153, United States
Beech Grove, Indiana 46107, United States
La Porte, Indiana 46350, United States
Des Moines, Iowa 50309, United States
Des Moines, Iowa 50314, United States
Wichita, Kansas 67214, United States
Madisonville, Kentucky 42431, United States
Shreveport, Louisiana 71130-3932, United States
Grosse Pointe Woods, Michigan 48236, United States
Mount Clemens, Michigan 48043, United States
Saint Joseph, Michigan 49085, United States
Maplewood, Minnesota 55109, United States
Minneapolis, Minnesota 55407, United States
Robbinsdale, Minnesota 55422-2900, United States
Cape Girardeau, Missouri 63701, United States
Columbia, Missouri 65203, United States
St Louis, Missouri 63141, United States
Billings, Montana 59101, United States
Missoula, Montana 59807, United States
Flemington, New Jersey 08822, United States
Morristown, New Jersey 07962, United States
Neptune City, New Jersey 07754-0397, United States
Manhasset, New York 11030, United States
Middletown, New York 10940-4199, United States
Rochester, New York 14642, United States
The Bronx, New York 10461, United States
Wilmington, North Carolina 28401, United States
Westerville, Ohio 43081, United States
Allentown, Pennsylvania 18105, United States
DuBois, Pennsylvania 15801, United States
Harrisburg, Pennsylvania 17105, United States
Scranton, Pennsylvania 18510, United States
Wilkes-Barre, Pennsylvania 18711, United States
Charleston, South Carolina 29425, United States
Spartanburg, South Carolina 29303, United States
Sioux Falls, South Dakota 57117-5039, United States
Knoxville, Tennessee 37920-6999, United States
Houston, Texas 77030, United States
San Antonio, Texas 78229-3900, United States
Seattle, Washington 98122-4307, United States
Seattle, Washington 98195-6043, United States
La Crosse, Wisconsin 54601, United States
Manitowoc, Wisconsin 54221-1450, United States
Wausau, Wisconsin 54401, United States